Saturday, 05 December 2020


Swiss CMO sets up manufacturing unit in China

03 September 2013 | News | By BioSpectrum Bureau

The new Siegfried plant will offer contract manufacturing for APIs, intermediates and finished oral drugs

The new Siegfried plant will offer contract manufacturing for APIs, intermediates and finished oral drugs

Singapore: Switzerland-based contract manufacturing organization (CMO), Siegfried Holdings, has started the construction of its new pharma manufacturing plant in Nantong, China.

The new plant, which would be the company's first facility in China, will have a capacity of 300 cubic meters. Siegfried will offer contract manufacturing for APIs, intermediates and finished oral drugs, along with other development services at its new plant.

Presently, Siegfried has plants in Switzerland, Malta and the US.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account